Taking Japanese DeepTech to the world.
Executed from Harwell.
An execution platform based at Harwell Campus, connecting Japanese and British technology, companies, and capital.
Japan already has outstanding technologies.
What is missing is the ability to execute globally.
DeepTech does not fail because of the technology.
It fails in global execution.
Japanese DeepTech is world-class.
Yet much of it stalls before real commercialisation.
The issue is not the quality of the science.
The real gap lies in the lack of global connection and on-the-ground execution.
Challenges on the Japanese side
-
No clear strategy for overseas markets
-
Limited access to investors
-
Little progress in local business development abroad
Challenges on the UK / European side
-
Difficulty accessing Japanese companies
-
Opaque decision-making structures
-
No trusted local execution partner
The problem is not the technology.
It is connection and execution.
An execution platform built from Harwell
Biospire is based at Harwell Campus.
Harwell is one of Europe’s leading DeepTech ecosystems, where research, business, and investment move in parallel.
Investors and Public Sector
We provide access not only to the UK, but also to VC and CVC networks across Europe and the United States.
In parallel, we are deeply embedded in government agencies, trade bodies, and innovation ecosystems centred on Japan and the UK.
We work across all three layers — policy, capital, and industry — to create connections that can actually be executed.
This is not about introductions.
It is about direct access to the real arenas of policy and investment.
DeepTech Companies
We connect clients directly with startups, scale-ups, and industrial players centred around Harwell, including major pharma and other strategic industry participants.
This is not passive networking.
We build practical business relationships and operational partnerships that move projects forward.
Not a network on paper.
A network that actually works in practice.
Research Institutions and Universities
In addition to strong links with leading universities across the UK and Europe, we provide direct access to the 16 national-level research institutes concentrated at Harwell.
This includes world-leading infrastructure such as:
-
RAL (Rutherford Appleton Laboratory)
-
Diamond Light Source
We do not simply “access research.”
We work from within the research environment itself.
We are not advisors.
We enter the market, work on the ground, and help turn projects into real businesses.
Connecting Japan and the UK at the level of execution
Biospire builds executable routes between Japan and the United Kingdom.
We are not simply a market entry advisor.
We are a partner that connects technology, business, and capital on the ground — and stays involved through implementation.
Japan → UK / Europe
-
Market execution support in the UK and Europe, including PoC design and commercialisation
-
Investor and CVC access, with fundraising support
-
Business development through the Harwell / Oxford ecosystem
-
UK entity set-up and operational support
UK / Europe → Japan
-
Strategic alliance building with Japanese corporates and industry players
-
Route-to-market design and market entry execution
-
Licensing and joint development support
-
Business partnership development and adoption by major companies
We operate as an Execution Partner —
entering the field, driving execution, and delivering outcomes.
Leadership that delivers execution
Biospire’s strength does not lie in its network alone.
It lies in the people who know how to execute.
Across both Japan and the UK, the business is led directly by experienced operators who have spent more than 25 years building and driving real projects.
Masashi Matsunaga, PhD
CEO / Co-founder
-
Over 25 years of business development and company-building experience across Japan and the UK
-
Specialised in DeepTech and life sciences
-
Proven track record spanning government, venture capital, and major corporates
-
Has led numerous global expansion projects for Japanese companies, as well as market entry projects for overseas companies entering Japan
-
“We have not merely envisioned a Japan–UK bridge.
-
We have built and executed it.”
Tim Hart, PhD
Director / Co-founder
-
More than 30 years of experience in technology commercialisation and innovation delivery
-
Extensive track record across universities, research institutions, startups, and corporates
-
Practical lead for DeepTech business development and commercialisation in the UK
-
Built strong industry–academia–investment networks centred on Oxford and Harwell
-
“Turning technology into business is not a theory.
It is a process we execute on the ground.”
Mentor Layer
A specialist team that supports execution
Areas of expertise
-
Technical assessment (life sciences, materials, energy, AI)
-
Investment strategy and finance
-
Business development and go-to-market design
-
Regulation, clinical strategy, and industrial partnerships
Biospire executes one of the most difficult transitions in DeepTech:
moving from technology to market.
We work deeply within both ecosystems — the UK (Oxford–Harwell) and Japan — connecting researchers, companies, and investors while turning opportunities into real businesses.
We work deeply within both ecosystems — the UK (Oxford–Harwell) and Japan — connecting researchers, companies, and investors while turning opportunities into real businesses.
Our value does not lie in strategy alone.
It lies in execution.
What we have executed
Biospire creates value not through ideas, but through execution.
The following are examples of projects we have actually driven in the field.
Harwell Japan Day
Harwell Japan Day was designed as a flagship execution-led programme connecting companies, startups, and government stakeholders from the UK and Japan.
Built around Harwell as a real commercial base, the objective was not simple exchange, but to create a setting where opportunities, decisions, and business projects could actually move forward.
The programme was structured not as networking for its own sake, but as a platform where the next action could begin immediately.
Process
-
Curated participants in advance, designing exactly who should meet whom
-
Structured sessions and speaker placements to create a pipeline for real opportunities
-
Designed follow-up from the outset, so that first meetings could move directly towards business discussions
Outcomes
-
Multiple business collaborations and joint explorations were launched and progressed into ongoing opportunities
-
Built sustained relationships among key players on both the UK and Japanese sides
-
Created direct access to decision-makers, including government stakeholders and investors
We do not stop at the event itself.
We design networks that lead to decisions and real projects.
Global Expansion of Japanese Startups through UK Execution
Support for Japanese startup expansion has historically begun through central government-led programmes involving the Ministry of Health, Labour and Welfare, METI, the Tokyo Metropolitan Government, and others.
That execution model is now being extended to regional innovation cities across Japan.
Programmes based in Oxford and Harwell are not overseas study tours.
They are execution-led models designed to support real business connections, partnerships, and even company formation on the ground.
Process
-
Reframed each startup’s technology, market positioning, and narrative, including Guy Kawasaki-style pitch design where appropriate
-
Translated each opportunity into a form that could resonate with UK investors, corporates, and research institutions
-
Supported meetings, negotiations, and PoC design on the ground, turning one-off introductions into commercialisation processes
Outcomes
-
Multiple Japanese startups completed UK company formation
-
Joint development projects and PoCs were launched with UK companies and research institutions
-
Progressed companies into investor engagement and fundraising processes
-
Built the basis for scaling the model from central government programmes to regional city deployment
Global expansion should not end with travel or ecosystem tours.
Execution means securing a position in the market.
Japan Market Entry for UK Startups through the “Japan Strategist” Function
For UK startups, Japan is an attractive market — but one with high barriers to entry due to language, business culture, and decision-making differences.
At a time when local hiring and entity establishment are difficult, Biospire steps in as a Japan Strategist: an internalised execution function that integrates strategy, corporate engagement, and negotiation.
Process
-
Redefined UK technologies and products for the Japanese market
-
Structured proposals to fit Japanese corporate decision-making processes, including ringi approval and validation pathways
-
Took on practical responsibility for meetings, negotiations, and commercial adjustments
Outcomes
-
Secured joint development projects and commercial agreements with Japanese companies
-
Enabled entry into Japan without requiring an immediate local team
-
Created ongoing partnerships and revenue opportunities
Japan entry should not be outsourced at arm’s length.
It should be executed as an internal strategic function.
Providing Directorship to DeepTech Companies as an Internal Execution Model
In DeepTech companies, science, business, and fundraising are tightly interlinked.
External advisory alone is often not enough to influence decision-making at the level required.
For this reason, Biospire provides Directorship-level involvement, entering the company internally and taking responsibility for strategy and operations from within.
Process
-
Participated directly in board-level decision-making across business, R&D, and fundraising
-
Designed and managed strategy across universities, research institutions, and investors
-
Drove the cycle of PoC → fundraising → commercialisation from inside the company
Outcomes
-
Built international research collaboration structures and R&D foundations
-
Reframed investor-facing narrative and capital strategy
-
Established business and organisational structures designed for global expansion
We do not advise from the outside.
We step inside the business and act with executive responsibility.
How we execute
Biospire is not a strategy consultancy.
What we provide is a set of execution functions grounded in the local ecosystem.
Using Harwell as our operational base, we build not just connections between Japan and the UK, but a structure through which business can continue to flow.
ENTRY (Designing the point of entry)
From companies, startups, and public-sector stakeholders in both Japan and the UK, we curate participants based on real potential for project formation.
We design the very first interaction on the assumption that it should lead to business.
Not an introduction for its own sake.
A first meeting designed from the outset to become a real opportunity.
EXECUTION
From deal design and PoC development to negotiation, company formation, and partnership creation, we operate as an execution function on the ground.
Where necessary, we enter the company itself and help accelerate decision-making from within.
We do not support from the outside.
We step inside and move things forward.
EXECUTION
We do not stop at a single project.
By involving investors, government, and research institutions, we expand individual opportunities into repeatable and continuous business flows.
From Harwell, we help build the platform for expansion across the UK and Europe.
Biospire is not a company that merely “connects people.”
It is a company that designs and implements the structures that make business move.
SCALE
Get in Touch
Atlas Centre
Rutherford Appleton Laboratory
Harwell Campus
OX11 0QX
United Kingdom
